Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.54 USD | +18.38% | -12.19% | -56.97% |
Mar. 27 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Mar. 27 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.34M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-0.68
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Moleculin Biotech, Inc.
1 day | +18.38% | ||
1 week | -12.19% | ||
Current month | -41.28% | ||
1 month | -40.04% | ||
3 months | -47.98% | ||
6 months | -8.78% | ||
Current year | -56.97% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 15-07-27 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 16-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Michael Cannon
BRD | Director/Board Member | 78 | 15-06-30 |
John Climaco
BRD | Director/Board Member | 55 | 17-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 5.54 | +18.38% | 89,261 |
24-03-26 | 4.68 | -10.86% | 92,008 |
24-03-25 | 5.25 | -7.97% | 915,721 |
24-03-22 | 5.705 | -13.96% | 98,642 |
24-03-21 | 6.63 | +5.09% | 44,752 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.97% | 12.34M | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.79% | 210B | |
+1.00% | 210B | |
-6.69% | 201B | |
-3.51% | 157B |